Terazosin 69452-0332-32
- Manufacturer
- Bionpharma Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 11, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA075667
Need to source Terazosin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Terazosin Hydrochloride | 5 mg/1 |
Drug Class
Adrenergic alpha-Antagonists [MoA]alpha-Adrenergic Blocker [EPC]
Selected Package
69452-0332-32Selected1000 CAPSULE in 1 BOTTLE (69452-332-32)
Other packages for this product(1)
100 CAPSULE in 1 BOTTLE (69452-332-20)